welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Rofecoxib, a Selective Cyclooxygenase-2 Inhibitor, on Rectal Polyps in Familial Adenomatous Polyposis Patients
source: Clinical cancer research
authors: Tetsuro Higuchi, Takeo Iwama, Keigo Yoshinaga, Masahiro Toyooka, Kenichi Sugihara, Makoto M Taketo,summary/abstract:
PURPOSE : The aim of this study was to examine the effect of a specific cyclooxygenase-2 inhibitor, rofecoxib, on rectal polyps in familial adenomatous polyposis patients.
EXPERIMENTAL DESIGN : This was a randomized, double-blind, placebo-controlled study of the efficacy and safety of rofecoxib in the rectum. Initially, 21 patients were assigned randomly in a 1:1 ratio to receive either 25 mg rofecoxib once a day or a placebo p.o. for 9 months. Patients underwent endoscopy at the beginning of the study and then every 3 months thereafter. We reviewed the videotapes to measure the number and size of polyps in the same area throughout the study period in each individual patient.
RESULTS : The polyp number, measured as the percentage of change from the baseline values, was significantly decreased in the rofecoxib group at 3, 6, and 9 months. At 9 months, the polyp number in the rofecoxib group decreased by 6.8% from the baseline values, whereas that in the placebo group increased by 3.1%. The 9.9% difference between the rofecoxib and placebo groups was statistically significant (P = 0.004). At 9 months, the rofecoxib group showed a significant reduction from the baseline in polyp size as compared with the placebo group (-16.2% versus 1.5%; P < 0.001). There was no statistically significant increase in the incidence of any adverse events in treatment with rofecoxib compared with placebo (P = 0.922).
CONCLUSIONS : In this study, once-daily treatment with 25 mg rofecoxib, a cyclooxygenase 2-specific inhibitor, significantly decreased the number and size of rectal polyps in familial adenomatous polyposis patients.organization: Tokyo Medical and Dental University
read more full text source
expertly curated content related to this topic
Woman with Ostomy Bag Refused Entry to Bathroom with Disability AccessThat’s the message English blogger Sam...
Are there any Alternative Medical Practices you would Recommend? If Yes, Why?Consider taking turmeric. It has been st...
Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature ReviewPURPOSE : Iron and/or vitamin B12 defici...
Chemoprevention of Colorectal CancerColorectal cancer has become one of the ...
Laparoscopic Total Colectomy (TPC) for Familial Adenomatous Polyposis – A Case ReportA 30-year-old man was admitted with anem...
New treatment reduces precancerous polyps in hereditary cancer patientsInheriting a mutation in the APC gene le...
Bonnies Diary March 08https://jtvcancersupport.com/embed/46053...